學術產出-Periodical Articles

Article View/Open

Publication Export

Google ScholarTM

政大圖書館

Citation Infomation

題名 On the Assessment of Similarity of Drug Dissolution Profiles—A Simulation Study
作者 Ju, Huey Lin
貢獻者 統計學系
關鍵詞 Dissolution; Bioequivalence; ANOVA; Split-plot; Time series
日期 1997-10
上傳時間 15-Dec-2015 18:12:47 (UTC+8)
摘要 In vitro dissolution has been recognized as an important element in drug development to assure the quality of drug products. It determines the rate and extent of the drug release and could be used as a surrogate for bioequivalence (BE) trials under certain conditions. Although methods for assessing the similarity of dissolution profiles between two drug products are available in the literature, most of them do not provide strong statistical and/or scientific justifications. This paper examines the properties of some commonly used methods and compares the results via a simulation study under the situations where the dissolution profile can be approximated by a linear or quadratic relationship over time. The similarity factor stated in the United States Food and Drug Administration (FDA) guideline (1) and the time series approach proposed by Chow (2) are also included. The results show that Chow`s method is very sensitive to the variation in the amount dissolved. Both methods are more relaxed and have a lower probability of declaring dissimilarity than the others.
關聯 Therapeutic Innovation & Regulatory, vol. 31 no. 4, 1273-1289
資料類型 article
DOI http://dx.doi.org/10.1177/009286159703100427
dc.contributor 統計學系
dc.creator (作者) Ju, Huey Lin
dc.date (日期) 1997-10
dc.date.accessioned 15-Dec-2015 18:12:47 (UTC+8)-
dc.date.available 15-Dec-2015 18:12:47 (UTC+8)-
dc.date.issued (上傳時間) 15-Dec-2015 18:12:47 (UTC+8)-
dc.identifier.uri (URI) http://nccur.lib.nccu.edu.tw/handle/140.119/79670-
dc.description.abstract (摘要) In vitro dissolution has been recognized as an important element in drug development to assure the quality of drug products. It determines the rate and extent of the drug release and could be used as a surrogate for bioequivalence (BE) trials under certain conditions. Although methods for assessing the similarity of dissolution profiles between two drug products are available in the literature, most of them do not provide strong statistical and/or scientific justifications. This paper examines the properties of some commonly used methods and compares the results via a simulation study under the situations where the dissolution profile can be approximated by a linear or quadratic relationship over time. The similarity factor stated in the United States Food and Drug Administration (FDA) guideline (1) and the time series approach proposed by Chow (2) are also included. The results show that Chow`s method is very sensitive to the variation in the amount dissolved. Both methods are more relaxed and have a lower probability of declaring dissimilarity than the others.
dc.format.extent 117 bytes-
dc.format.mimetype text/html-
dc.relation (關聯) Therapeutic Innovation & Regulatory, vol. 31 no. 4, 1273-1289
dc.subject (關鍵詞) Dissolution; Bioequivalence; ANOVA; Split-plot; Time series
dc.title (題名) On the Assessment of Similarity of Drug Dissolution Profiles—A Simulation Study
dc.type (資料類型) article
dc.identifier.doi (DOI) 10.1177/009286159703100427
dc.doi.uri (DOI) http://dx.doi.org/10.1177/009286159703100427